(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals jumping 13.71% to $1.99 on Friday, after two sequential sessions in a row of gains. NASDAQ rose 3.33% to $12,131.13, after two sequential sessions in a row of gains, on what was a very bullish trend exchanging session today.
Today’s last reported volume for Inovio Pharmaceuticals is 9770660, 70.58% above its average volume of 5727830.
Inovio Pharmaceuticals’s last close was $1.75, 83.06% under its 52-week high of $10.33.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 138.1% for the ongoing quarter and a decline by 33% for the next. The company’s growth estimates for the current quarter is 17.9% and a drop 3.4% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 85%, now sitting on 1.77M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Inovio Pharmaceuticals’s stock is considered to be overbought (>=80).
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $1.99 at 22:54 EST, way under its 52-week high of $10.33 and way above its 52-week low of $1.60.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s value is way below its 50-day moving average of $3.03 and way under its 200-day moving average of $5.40.
More news about Inovio Pharmaceuticals (INO).